B1 - non-controlled pharmaceuticals and vivatrol (90F) 2ND QTR. FY 2025 january 01, 2025 - march 14, 2025
Ended Awarded Last action
- Contract number
- 15B50225F00000033
- Awardee
-
Mckesson Corporation UEI S1RUKWWRYFL6 Part of Mckesson Corporation
- Awarding agency
-
Federal Correctional Complex Beaumont
Correctional Facilities, Department of Justice
- Obligated
- $437,399
Award facts
- Contract value 100% obligated
- $437,399.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Irving, TX 75039, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$32,599 | |
| Other Administrative Action | -$52,296 | |
| Other Administrative Action | $39,043 | |
| Other Administrative Action | $72,988 | |
| Funding Only Action | $60,000 | |
| Funding Only Action | $44,000 | |
| Other Administrative Action | $42,607 | |
| Funding Only Action | $86,129 | |
| Other Administrative Action | $22,529 | |
| Original award | $155,000 |
About this award
McKesson Corporation has been awarded a delivery order valued at $437,399.32 for non-controlled pharmaceuticals and Vivitrol (extended-release naltrexone) to support the Federal Correctional Complex Beaumont, a civilian facility operated by the Federal Bureau of Prisons under the Department of Justice. The contract is structured as a firm fixed-price delivery order with performance running from January 1, 2025 through March 14, 2025 as part of the broader FY 2025 pharmaceutical procurement cycle (October 2024 – September 2025). This award carries no set-aside designation, reflecting McKesson's established competitive standing as a large business contractor in federal pharmaceutical procurement. The work will be performed from McKesson's primary distribution location in Irving, Texas.
This delivery order represents a continuation of McKesson's extensive pharmaceutical supply relationship with the Federal Bureau of Prisons, through which the company provides critical medication support to correctional facilities nationwide. Vivitrol is a medication-assisted treatment option commonly used in federal correctional healthcare for opioid use disorder management, while non-controlled pharmaceuticals support routine inmate healthcare operations. McKesson's delivery orders under this contract vehicle have historically ranged significantly in value, reflecting the variable nature of correctional healthcare pharmaceutical needs across the Bureau of Prisons system. The ultimate completion date is established as September 30, 2025.
Quick answers
Who was awarded contract 15B50225F00000033?
15B50225F00000033 was awarded to Mckesson Corporation by Federal Correctional Complex Beaumont (Correctional Facilities) on January 1, 2025.
How much is contract 15B50225F00000033 worth?
The government has obligated $437,399 on 15B50225F00000033.
Is contract 15B50225F00000033 an order under another contract?
Yes. 15B50225F00000033 is a delivery order under 36W79720D0001, an indefinite delivery contract.
Was contract 15B50225F00000033 competed?
The extent of competition for 15B50225F00000033 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award